v3.26.1
EQUITY INCENTIVE PLANS (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement, Expensed and Capitalized, Amount Total stock-based compensation expense recognized on the condensed consolidated statement of operations as follows:
Three months ended June 30,Six months ended June 30,
2026202520262025
Direct cost of sales, excluding depreciation and amortization
$384 $171 $794 $313 
Selling, general and administrative
6,108 457 6,962 835 
Research and development
1,024 372 2,093 682 
Total stock-based compensation$7,516 $1,000 $9,849 $1,830 
Summary of Stock Options
Presented below is a summary of the status of the time vested stock options under the Equity Plans for the six months ended June 30, 2026:
Number of
Options
Weighted-Average
Exercise Price
Outstanding at January 1, 20261
12,868,649$2.78 
Granted
2,032,22711.42 
Exercised
1,497,2972.22 
Forfeited
355,6764.85 
Expired
34,0223.15 
Outstanding at June 30, 202613,013,881$4.14 
_______________
(1)The January 1, 2026 balance has been adjusted from previously reported amounts to reflect an immaterial reduction of 377,671 options. This adjustment did not have a material impact on the Company's previously issued consolidated financial statements or share-based compensation expense.
Presented below is a summary of the status of the performance vested stock options under the Equity Plans for the six months ended June 30, 2026:
Number of
Options
Weighted-Average
Exercise Price
Outstanding at January 1, 2026
1,428,951$2.65 
Granted
$— 
Exercised
106,563$3.08 
Forfeited
$— 
Expired
$— 
Outstanding at June 30, 20261,322,388$2.61 
Schedule of Restricted Stock Unit Activity
Presented below is a summary of the status of the restricted stock units under the Plan for ended six months ended June 30, 2026:
Number of
RSUs
Weighted-Average
Grant Date Fair Value
Outstanding at January 1, 2026
182,786$4.65 
Granted
1,299,121$18.69 
Vested
$— 
Forfeited
$— 
Expired
$— 
Outstanding at June 30, 20261,481,907$16.96